Logo image of CVO.CA

COVEO SOLUTIONS INC-SUB VTG (CVO.CA) Stock Fundamental Analysis

Canada - TSX:CVO - CA22289D1078 - Common Stock

9.27 CAD
+0.15 (+1.64%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

4

CVO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 64 industry peers in the Software industry. The financial health of CVO is average, but there are quite some concerns on its profitability. CVO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CVO had negative earnings in the past year.
In the past year CVO had a positive cash flow from operations.
CVO had negative earnings in 4 of the past 5 years.
In multiple years CVO reported negative operating cash flow during the last 5 years.
CVO.CA Yearly Net Income VS EBIT VS OCF VS FCFCVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M -600M

1.2 Ratios

The Return On Assets of CVO (-10.20%) is comparable to the rest of the industry.
The Return On Equity of CVO (-18.58%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.2%
ROE -18.58%
ROIC N/A
ROA(3y)-9.13%
ROA(5y)-43.11%
ROE(3y)-14.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CVO.CA Yearly ROA, ROE, ROICCVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

CVO has a better Gross Margin (78.37%) than 85.71% of its industry peers.
CVO's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.53%
GM growth 5Y0.5%
CVO.CA Yearly Profit, Operating, Gross MarginsCVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -500

6

2. Health

2.1 Basic Checks

CVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVO has been reduced compared to 1 year ago.
CVO has less shares outstanding than it did 5 years ago.
CVO has a better debt/assets ratio than last year.
CVO.CA Yearly Shares OutstandingCVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CVO.CA Yearly Total Debt VS Total AssetsCVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.31, we must say that CVO is in the distress zone and has some risk of bankruptcy.
CVO has a Altman-Z score of 0.31. This is in the lower half of the industry: CVO underperforms 60.32% of its industry peers.
CVO has a debt to FCF ratio of 0.53. This is a very positive value and a sign of high solvency as it would only need 0.53 years to pay back of all of its debts.
The Debt to FCF ratio of CVO (0.53) is better than 82.54% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that CVO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.04, CVO is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.53
Altman-Z 0.31
ROIC/WACCN/A
WACC10.62%
CVO.CA Yearly LT Debt VS Equity VS FCFCVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

2.3 Liquidity

CVO has a Current Ratio of 1.77. This is a normal value and indicates that CVO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.77, CVO is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
CVO has a Quick Ratio of 1.77. This is a normal value and indicates that CVO is financially healthy and should not expect problems in meeting its short term obligations.
CVO's Quick ratio of 1.77 is fine compared to the rest of the industry. CVO outperforms 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
CVO.CA Yearly Current Assets VS Current LiabilitesCVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

The earnings per share for CVO have decreased strongly by -350.00% in the last year.
The Revenue has been growing slightly by 6.90% in the past year.
Measured over the past years, CVO shows a quite strong growth in Revenue. The Revenue has been growing by 19.16% on average per year.
EPS 1Y (TTM)-350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-471.43%
Revenue 1Y (TTM)6.9%
Revenue growth 3Y15.5%
Revenue growth 5Y19.16%
Sales Q2Q%10.33%

3.2 Future

The Earnings Per Share is expected to grow by 37.90% on average over the next years. This is a very strong growth
CVO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.53% yearly.
EPS Next Y-131.08%
EPS Next 2Y60.12%
EPS Next 3Y37.9%
EPS Next 5YN/A
Revenue Next Year12.06%
Revenue Next 2Y14.4%
Revenue Next 3Y14.15%
Revenue Next 5Y32.53%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CVO.CA Yearly Revenue VS EstimatesCVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
CVO.CA Yearly EPS VS EstimatesCVO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVO. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 100.42, CVO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CVO indicates a somewhat cheap valuation: CVO is cheaper than 60.32% of the companies listed in the same industry.
CVO is valuated expensively when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 100.42
CVO.CA Price Earnings VS Forward Price EarningsCVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100 -150

4.2 Price Multiples

61.90% of the companies in the same industry are more expensive than CVO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 48.26
EV/EBITDA N/A
CVO.CA Per share dataCVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

CVO's earnings are expected to grow with 37.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.12%
EPS Next 3Y37.9%

0

5. Dividend

5.1 Amount

No dividends for CVO!.
Industry RankSector Rank
Dividend Yield N/A

COVEO SOLUTIONS INC-SUB VTG

TSX:CVO (9/12/2025, 7:00:00 PM)

9.27

+0.15 (+1.64%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-03 2025-11-03
Inst Owners45.05%
Inst Owner ChangeN/A
Ins Owners0.43%
Ins Owner ChangeN/A
Market Cap922.74M
Analysts75
Price Target12.32 (32.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1087.82%
Min EPS beat(2)-1088.12%
Max EPS beat(2)-1087.53%
EPS beat(4)1
Avg EPS beat(4)-312.89%
Min EPS beat(4)-1088.12%
Max EPS beat(4)956.11%
EPS beat(8)5
Avg EPS beat(8)-87.88%
EPS beat(12)8
Avg EPS beat(12)-51.42%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-1.06%
Max Revenue beat(2)-0.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-1.06%
Max Revenue beat(4)0.16%
Revenue beat(8)2
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)0.06%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)23.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-119.98%
EPS NY rev (1m)-118.18%
EPS NY rev (3m)-118.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 100.42
P/S 4.88
P/FCF 48.26
P/OCF 44.01
P/B 5.45
P/tB 7.23
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.09
Fwd EY1%
FCF(TTM)0.19
FCFY2.07%
OCF(TTM)0.21
OCFY2.27%
SpS1.9
BVpS1.7
TBVpS1.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.2%
ROE -18.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.37%
FCFM 10.11%
ROA(3y)-9.13%
ROA(5y)-43.11%
ROE(3y)-14.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.53%
GM growth 5Y0.5%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.53
Debt/EBITDA N/A
Cap/Depr 15.75%
Cap/Sales 0.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 0.31
F-Score6
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)12.77%
Cap/Depr(5y)21.5%
Cap/Sales(3y)1.15%
Cap/Sales(5y)2.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-471.43%
EPS Next Y-131.08%
EPS Next 2Y60.12%
EPS Next 3Y37.9%
EPS Next 5YN/A
Revenue 1Y (TTM)6.9%
Revenue growth 3Y15.5%
Revenue growth 5Y19.16%
Sales Q2Q%10.33%
Revenue Next Year12.06%
Revenue Next 2Y14.4%
Revenue Next 3Y14.15%
Revenue Next 5Y32.53%
EBIT growth 1Y4.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year108.6%
EBIT Next 3Y72.78%
EBIT Next 5Y120.7%
FCF growth 1Y275.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y327.55%
OCF growth 3YN/A
OCF growth 5YN/A